Victoria Gonzalez
About Victoria Gonzalez
Victoria Gonzalez is the Associate Director of Clinical Operations Spain at BeiGene, with over 20 years of experience in clinical operations and pharmaceutical research.
Title and Company
Victoria Gonzalez currently holds the position of Associate Director, Clinical Operations Spain at BeiGene in Madrid, Spain. She joined BeiGene in October 2021.
Previous Roles
Victoria Gonzalez has a substantial background in clinical operations and pharmaceutical research. Before joining BeiGene, she was the Head of Clinical & Preclinical Department at Sylentis (Grupo Zeltia) from 2007 to 2021. Prior to this, she served as a Project Manager at Chemo Group in 2007 for eight months. Additionally, she worked as a Scientist and Clinical Research Associate (CRA) focusing on oncology projects at Biocompatibles UK (BTG group) from 2001 to 2007. Her early career includes a Research Assistant role at King's College of London from 2000 to 2001.
Education and Academic Background
Victoria Gonzalez has an extensive academic background in pharmacy and pharmaceutical sciences. She earned her Master of Pharmacy Degree (MPharm) from the Faculty of Pharmacy at Universidad Complutense, where she studied from 1995 to 2000. She further advanced her qualifications by obtaining a PhD from the School of Pharmacy and Biomolecular Sciences at the University of Brighton.
Experience in Clinical Operations
With over 20 years of experience in clinical operations, Victoria Gonzalez has developed a deep expertise in this field. At Sylentis, she led the Clinical & Preclinical Department for 14 years, gaining substantial experience in both clinical and preclinical studies. Her role at Biocompatibles UK involved significant work on oncology projects, further emphasizing her specialized skills in clinical research.
Project Management Expertise
Victoria Gonzalez's extensive experience in project management is evidenced by her role as Project Manager at Chemo Group in 2007. Her proficiency in managing complex projects in the pharmaceutical sector contributes significantly to her current role at BeiGene.